Colorectal cancer and new therapeutic developments in solid tumours
Molecular characterisation of colorectal cancer by liquid biopsy based on the analysis of ctDNA and CTCs. Application of radiomics in prognostic assessment. Study of the mechanisms of resistance to standard and targeted therapy and identification of new therapeutic targets. Development of clinical trials with drugs directed against potentially targetable alterations.
Direct and inverse multimorbidity in patients with complex diseases like CNS disorders, cancer or metabolic diseases.
Comprehend the unexpected associations between apparently different diseases, like cancer and certain diseases of the central nervous system.
